902
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Association of dialysate calcium concentration with fetuin a level and carotid intima-media thickness in peritoneal dialysis patients

, , , , &
Pages 65-68 | Received 13 Jun 2013, Accepted 19 Jul 2013, Published online: 13 Sep 2013

References

  • Marson BP, de Figueiredo CE, Tanus-Santos JE. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic Clin Pharmacol Toxicol. 2012;110:409–415
  • Zhou TB, Yin SS, Qin YH. Association of angiotensinogen M235T gene polymorphism with end-stage renal disease risk: a meta-analysis. Mol Biol Rep. 2013;40:765–772
  • Yakut ZI, Karadag R, Akcay A, Bavbek N, Akay H, Koktener A. Effect of dialysis type on orbital vascular flow in patients with end-stage renal disease. Ren Fail. 2012;34:691–696
  • Zhou TB, Yin SS. Association of endothelial nitric oxide synthase glu298asp gene polymorphism with the risk of end-stage renal disease. Ren Fail. 2013;35:573–578
  • Liu JH, Chen JY, Lin SY, et al. Comparing survival between peritoneal dialysis and hemodialysis patients with subclinical peripheral artery disease: a 6-year follow-up. Int J Med Sci. 2013;10:434–440
  • Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003;14:2366–2372
  • Onut R, Balanescu AP, Constantinescu D, Calmac L, Marinescu M, Dorobantu PM. Imaging atherosclerosis by carotid intima-media thickness in vivo: how to, where and in whom? Maedica (Buchar). 2012;7:153–162
  • Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke. 2003;34:2985–2994
  • Turkmen K, Tonbul HZ, Toker A, et al. The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients. Ren Fail. 2012;34:1229–1237
  • Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112:357–366
  • Singh M, Sharma PK, Garg VK, Mondal SC, Singh AK, Kumar N. Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol. 2012;64:1703–1708
  • Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20:1676–1685
  • Laughlin GA, Cummins KM, Wassel CL, Daniels LB, Ix JH. The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study. J Am Coll Cardiol. 2012;59:1688–1696
  • Cagli K, Basar N, Cagli K, et al. Association of serum fetuin-A with valvular calcium concentration in rheumatic mitral valve disease. J Heart Valve Dis. 2010;19:636–643
  • Taskapan MC, Taskapan H, Comert M, Temel I, Yagmur J, Ulutas O. Serum fetuin-A levels, QT dispersion and P dispersion in dialysis patients. Ren Fail. 2013;35:477--482
  • Heymann EP, Penny H, Goldsmith DJ. Vascular and arterial calcification in peritoneal dialysis patients–state-of-the-art 2012. Contrib Nephrol. 2012;178:189–194
  • El-Shehaby AM, Zakaria A, El-Khatib M, Mostafa N. Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients. Scand J Clin Lab Invest. 2010;70:575–582
  • Westenfeld R, Schafer C, Kruger T, et al. Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol. 2009;20:1264–1274
  • Kim JK, Moon SJ, Park HC, et al. Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis. Korean J Intern Med. 2011;26:320–327
  • Zhou TB. Signaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis. J Recept Signal Transduct Res. 2012;32:298–303
  • Zhou TB. Signaling pathways of apoE and its role of gene expression in glomerulus diseases. J Recept Signal Transduct Res. 2013;33:73–78
  • Zhou TB, Qin YH. The signaling pathways of LMX1B and its role in glomerulosclerosis. J Recept Signal Transduct Res. 2012;32:285–289
  • Zhou TB, Qin YH. Signaling pathways of prohibitin and its role in diseases. J Recept Signal Transduct Res. 2013;33:28–36
  • Kahnooj M, Masoomi M, Naderinasab A, Zaeem A, Sheikhvatan M. Relationship between calcium-phosphorus product and severity of valvular heart insufficiency in patients undergoing chronic hemodialysis. J Tehran Heart Cent. 2010;5:78–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.